Guidelines for appellate review of decisions of ALJs supported by the DAB’s Civil Remedies Division:
- Affecting a Provider’s Participation in the Medicare and Medicaid Programs
- In Cases under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and Related Statutes
- Affecting a Provider’s or Supplier’s Enrollment in the Medicare Program
- In Cases to which Procedures in 42 C.F.R. Part 1005 Apply
- In Social Security Administration Cases to which Procedures in 20 C.F.R. Part 498 Apply
- Relating to Imposition of Civil Money Penalties Based on Violations of the HIPAA Administrative Simplification Provisions
- Under the Program Fraud Civil Remedies Act of 1986
- Relating to Imposition of Civil Money Penalties Based on Violations of the Confidentiality Provisions of the Patient Safety and Quality Act
- In Food and Drug Administration Cases Other Than Tobacco Products Cases
- In Food and Drug Administration Tobacco Products Cases
Guidelines for appellate review of decisions of ALJs at the Department of the Interior Office of Hearings and Appeals:
- In Indian Self-Determination Act Declinations
- In Pre-Award Disputes under Title V of the Indian Self-Determination and Education Assistance Act
